BriaCell Therapeutics Corp. (BCT.TO) TSX
Currency In CAD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 24.15M |
| Enterprise Value | 14.3M |
| P/E Ratio | -0.39 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.93 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.62 |
Fiscal Year
| Fiscal Year | July 31, 2026 |
| Most Recent Quarter | July 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.47 |
| Return On Equity | -1.71 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -121,089 |
| EBITDA | -36.46M |
| Net Income | -35.42M |
| Diluted EPS | -7.07 |
Balance Sheet
| Total Cash | 20.53M |
| Total Cash/Share | 2.36 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 2.76 |
| Book Value Per Share | 1.79 |
Price History
| 52-Week Change | -63.33 |
| 52-Week High | 18 |
| 52-Week Low | 3.68 |
| Moving Average 50 Days | 5.22 |
| Moving Average 200 Days | 5.23 |
Statistics
| Average Volume | 7,285 |
| Shares Outstanding | 8.73M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | August 25, 2025 |
AD
